Curis Set For Transformative Year With Erivedge Skin Cancer ...

By Shirley Haley / Email the Author / ?The Pink Sheet? Feb. 6, 2012, Vol. 74, No. 6
New Products / Word Count: 1088 / Article # 00120206030

---

Executive Summary

Approved nearly six weeks before the March 8 PDUFA date, Erivedge (vismodegib) will be available to treat advanced basal cell cancers in a week or two for about $7,500 a month wholesale, partner Genentech said.

---

Already a Subscriber?

Log in for complete access.

Log In

---

Questions?

Call Toll-Free (800)?332-2181 or +1?(908)?547-2159.

---

Source: http://www.elsevierbi.com/publications/the-pink-sheet/74/6/curis-set-for-transformative-year-with-emerivedgeem-skin-cancer-approval?elsca2=rss&elsca1=pink

jets broncos thursday night football johnny jolly johnny jolly demi moore and ashton kutcher demi moore and ashton kutcher kim zolciak